Hepatitis B virus (HBV) X gene is known to exhibit a transcriptional activation function and is considered to play a major role in hepatocarcinogenesis. We determined a 20-bp promoter element for the HBV X gene transcription and found a binding protein to this promoter element, designated as an X-PBP. We then examined the effects of HBV X protein and p53 tumor suppressor gene product on X gene transcription from the 20-bp promoter element using the transient expression technique. Activity of the X gene promoter was stimulated by X protein expression, but, in contrast, was repressed by transfected normal p53 gene. On the other hand, mutant p53 gene product exhibited no repression. Moreover, the p53 repression of X gene transcription was canceled by X protein coexpression. Thus, the effects of X protein and normal p53 product appear to be mutually antagonistic in the regulation of X gene expression. However, mutated promoter elements which failed to bind to X-PBP still responded to X protein or p53, indicating that the process of X transactivation or p53 respression may be independent of X-PBP binding to the promoter element. Our data suggest that X protein could disrupt function of normal p53 protein in X gene-transfected cells. ᭧
INTRODUCTION
, but not for SV40 enhancer in CV-1 cells (Seto et al., 1990) . When focused on one particular Hepatitis B virus (HBV) is closely related not only to gene, the efficacy of transactivation was found to be acute or chronic hepatitis, but also to the development dependent on the cell line that was used in the experiof hepatocellular carcinoma (HCC) (for review, see Tiolment (Seto et al., 1989) . Thus, the XRE should be deterlais et al., 1985; Ganem and Varmus, 1987) . One of the mined, respectively, for each cell line. HBV genes, X, encodes a basic protein of 154 amino Although the reported observations and the proposed acids and has been implicated in the carcinogenicity of mechanisms were not, in fact, always consistent, it appears this virus as a major causative factor because of its ability that X protein exerts its transcriptional activation function to induce the transformation of rodent cells (Shirakata et via protein-protein interaction with cellular factors. Several al., 1989; Hohne et al., 1990; Rakotomahanina et al., 1994) reports have indicated that X protein activated some signal and to induce HCC in transgenic mice (Kim et al., 1991) . transduction factors (Kekule et al., 1993; Cross et al., 1993 ; The X protein is known to exhibit a transcriptional activa- Natoli et al., 1994a; Benn and Schneider, 1994) or DNA tion function for many viral and cellular genes without binding of some transcription factors (Natoli et al., 1994b) . binding to DNA (Spandau and Lee, 1988 ; for review, RosOn the other hand, X protein directly interacted with hepatic sner, 1992).
serine proteases, tryptase TL2, and tryptase TL1 (a member As to the responsive element for X protein (X-responof proteasome), as an inhibitor (Takada and Koike, 1990a ; sive element, XRE), AP-1 and AP-2 binding sequences Takada et al., 1994a) . This indicates the possibility that X were previously found in SV40 enhancer (Seto et al., protein activates the signal transduction pathway as well 1990), NFkB-like sequence in the HIV LTR (Siddiqui et as transcription by inhibiting the activity of serine proteases al., Twu et al., 1989a,b) , and the 26-bp XRE in HBV that might be involved in proteolytic cleavage of transcripenhancer I (Faktor et al., 1990) . Accordingly, the X protein tion factors or signal transduction factors. However, we was expected to transactivate a certain gene through a could not exclude the possibility that these observations different XRE in each cell line; for example, the AP-2 were indirect outcomes of the transcriptional activation of binding sequence responded to X protein in CV-1 cells several genes by X protein, because these serine proteases (Seto et al., 1990) , but not in HepG2 cells (Twu et al., are localized in the cytoplasm (Kido et al., 1990; Tanaka et 1989a) , and a kB-like sequence was reported to be the al., 1992), and X protein is detected mainly in the cytoplasm XRE for the HIV LTR in HepG2 cells (Siddiqui et al., 1989; (Siddiqui et al., 1987; Benn and Schneider, 1994) .
As it is increasingly important to understand how X gene expression is regulated, we previously analyzed X containing region and found that the 58-bp region, 130 activity was counteracted by the presence of X protein.
From the viewpoint of functional disruption of normal p53 bp upstream from the first ATG codon of X ORF, has promoter activity (Nakamura and Koike, 1992) . In addiin the nucleus by X protein coexpression, the transactivation mechanism in X gene-transfected cells is discussed. tion, a ubiquitous protein (complex), designated as an X-PBP (X promoter binding protein), was shown to bind this 58-bp DNA (Nakamura and Koike, 1992; Yaginuma et al., MATERIALS AND METHODS 1993) . In this study, deletion analyses were performed Plasmid DNAs on this 58-bp region and a small 20-bp region of promoter activity of the X gene was determined. We then quespX58pCAT, pX58pM1CAT, and pX58pM2CAT were pretioned whether X protein regulates the X gene promoter.
viously described by Nakamura and Koike (1992) . pX58pM4 The promoter activity of the 20-bp DNA was activated by Ç pX58pM7CAT, pX58pM7mCAT (SphI site was mutated X protein expression, but we were not able to observe the from GCATGC to TTTTTT), pXMP1CAT Ç pXMP3CAT, and direct involvement of X-PBP in the process of promoter pXMP2mCAT (the SphI site was mutated from GCATGC to activation by X protein.
GACTGC) were constructed by ligation of each chemically The p53 tumor suppressor gene product is mainly losynthesized double-stranded mutant X promoter DNA into cated in the nucleus and has pleiotropic functions, inthe HindIII site of pSV00CAT (Araki et al., 1988) . pHBVX-1 cluding the control of genomic instability (Harris and (Kobayashi and Koike, 1984; Yaginuma et al., 1987) , which Hollstein, 1993). The p53 protein controls gene transcripwas constructed by insertion of a 0.87-kb StuI/BglII (nt tion by binding to the specific DNA sequence and to 872-1858) fragment of HBV DNA containing the X gene other cellular factors (such as Mdm-2, TBP, and WT1) and expression unit into the BamHI site of pBR322, was used may be involved in DNA replication and repair processes as the X gene expression plasmid. Expression plasmids (Seto et al., 1992; Kastan et al., 1992; Oliner et al., 1992;  pEFX and pEFX-DRsaI were also used as the wild-type or Momand et al., 1992; Dutta et al., 1993) . Mutations on mutant X gene expression, where the wild-type or DRsaI p53 were found in a wide variety of human cancers (Har- (Arii et al., 1992 ) mutant X gene ORF was driven under the ris and Hollstein, 1993; Hollstein et al., 1991) . p53 miscontrol of the EF1a (elongation factor 1a) gene promoter sense mutants not only lose normal function, but often . p53 expression plasmids pCMVp53(norgain oncogenic properties (Wolf et al., 1984; Dittmer et mal), pCMVOM1, pCMVp53d(346-393), pCMVp53d(302-al., 1993; Gerwin et al., 1992) . In virally transformed cells, 393), pCMVp53d(283-393), and pCMVp53DN were conp53 protein complexes with viral oncoproteins, such as structed by inserting the normal or mutant p53 ORFs into the SV40 large tumor antigen(T) (Lane and Crawford, a CMV vector (CLONTECH). pCMVOM1 is a point mutant 1979; Linzer and Levine, 1979) , the adenovirus E1B prop53, in which Glu was replaced by Gly (aa 266) (Sakai and tein (Sarnow et al., 1982) , the human papillomavirus E6 Tsuchida, 1992). pCMVp53d(346-393), pCMVp53d(302-393), protein (Dyson et al., 1989) , and the Epstein-Barr virusand pCMVp53d(283-393) are mutant p53s which have lost encoded nuclear antigen EBNA-5 (Subler et al., 1992) . the C-terminal region from aa 346, 302, and 283, respecThese protein-protein interactions can inactivate p53 tively, to the C-terminus (Tsutsumi-Ishii et al., 1995) . functions, e.g., sequence-specific DNA binding and gene pCMVp53DN is an N-terminal deletion (aa 1-159) mutant. transactivation and, thus, are important to viral oncogenicity. On the basis of the general acceptance that the Cell line, DNA transfection, CAT activity assay, and tumor suppressor gene p53 regulates transcriptional iniNorthern blot hybridization tiation of a variety of viral and cellular genes by direct HepG2 is a hepatoblastoma cell line containing normal interaction with the basal transcription factors (Zambetti p53 . Saos-2 (ATCC HTB85), which lacks endogenous p53 et al., 1992; Kern et al., 1991; Farmer et al., 1992; Seto (Masuda et al., 1987) , is a human osteosarcoma cell line. Ragimov et al., 1993) , we questioned whether HuH-7 is a hepatocellular carcinoma cell line which has the p53 gene product directly regulates the X gene promutant p53 (Bressac et al., 1990) . DNA transfection, CAT moter. As we preliminarily reported that p53 repressed activity assay, and Northern blot hybridization were car-X gene transcription from the 58-bp promoter-containing ried out as described (Takada and Koike, 1990b) . To DNA using the CAT assay system (Takada et al., 1994b) , quantify the reaction products of the CAT assay, radioacin the present study, we examined the promoter activity tive spots were cut out from the silica gel plate and of the 20-bp sequence in the presence of transfected their radioactivity was measured with a liquid scintillation normal p53 gene. As a result, the 20-bp promoter activity counter. Relative activity (RA) was calculated and dewas clearly repressed by transfected normal p53 gene, picted in each respective figure. but not by its mutants. In contrast, under similar conditions, the muscle creatine kinase gene promoter was Electrophoretic mobility shift assay activated (Takada et al., 1994b) , consistent with the previous data (Weintraub et al., 1991; Zambetti et al., 1992) .
Nuclear extracts were prepared according to the method of Dignam et al. (1983) . Binding reactions were Interestingly, when normal p53 gene was coexpressed with X gene, the repressive effect of p53 on the promoter carried out in 10 ml of the buffer containing 10 mM Tris-HCl (pH 7.5), 50 mM NaCl, 1 mM DTT, 1 mM EDTA, 5% glycerol, 200 mg/ml poly(dA-dT)-poly(dA-dT) (Pharmacia), 300 mg/ml protein concentration of nuclear extract, and 2 1 10 4 cpm of 32 P-labeled probe DNA for 20-30 min at room temperature, unless otherwise indicated. One microliter of dye solution [10 mM Tris-HCl (pH7.5), 50% glycerol, 0.4% bromophenol blue, 0.4% xylene cyanol] was added to each sample, before it was loaded onto a 4% acrylamide gel containing 6.7 mM Tris-HCl (pH7.5), 1 mM EDTA, 3.3 mM NaoAc, and 2.5% glycerol and then run in 6.7 mM Tris-HCl (pH7.5), 3.3 mM NaoAc, and 4 mM EDTA. In the supershift experiments, 300 ng of antip53 antibody PAb421, PAb1801 (Oncogene Science), or anti-SV40 T-Ag antibody (Oncogene Science) was in- 
RESULTS
indicate the cleavage sites of StuI, BalI, SphI, and MboI, respectively. The BalI/MboI fragment is the 58-bp DNA fragment which contains the Determination of a small essential region for the X gene promoter (Nakamura and Koike, 1992) . Various sections of this promoter activity of HBV X gene 58-bp DNA or their mutants indicated in the figure were chemically synthesized and connected to pSV00CAT, and their promoter activities
The promoter-containing region of the HBV X gene were measured by CAT activity assay using 2 or 10 mg of each CAT was previously identified by CAT activity assay as the construct per 10-cm dish. Relative promoter activity of each inserted DNA is shown to the right. Location of the 20-bp promoter is presented 58-bp BalI/MboI DNA fragment (nt 1085-1142) (Nakaby the hatched box and its nucleotide sequence is shown below. In mura and . This 58-bp DNA fragment has no the MP2m mutant, the sequence GCATGC at the SphI site in MP2 DNA enhancer activity, but contains the major start site of X was changed to GACTGC.
mRNA (Nakamura and Koike, 1992; Yaginuma et al., 1993) . It was interesting to determine a small essential sequence for the promoter activity of X gene, because of pX58pCAT, was tested for its CAT activity. pX58pM2CAT exhibited about one-eighth (162 versus the promoter-containing region (58-bp DNA fragment) (nt 1085-1142) possesses none of the typical promoter se-1250) the CAT activity of pX58pCAT, which corresponded to 12.5-fold that of pX58pM4CAT (data not shown). The quences, such as the TATA, GC, and CAAT boxes. As shown in Fig. 1 , various promoter-containing DNAs essential region for the promoter activity could thus be restricted to the 20-bp MP2 DNA sequence (nt 1102-within the 58-bp DNA fragment were synthesized, introduced into the pSV00CAT plasmid, and analyzed for their 1121), where the major start site of X mRNA was present. The 20-bp sequence is separated from the NF-1 binding promoter activity by CAT activity assay, using HepG2 cells as the host. The promoter activity was found to site (nt 1088-1100) (Kobayashi and . We previously demonstrated the interaction of X-PBP reside in the 20-bp MP2 DNA (nt 1102-1121) in the pXMP2CAT plasmid, whose sequence is shown at the with the promoter region of the X gene by a mobility shift assay using the 58-bp BalI/MboI DNA fragment as the bottom of Fig. 1 . This 20-bp sequence overlaps the X-PBP protected region (nt 1096-1117), which was detected probe (Nakamura and Koike, 1992) . DNaseI footprinting experiments localized the binding site at the sequence beas a major shifted band by a mobility shift assay using sonicated salmon sperm DNA as a nonspecific competitween nt 1096 and 1117, which contains an 8-bp palindromic sequence with an SphI cleavage site (nt 1110) at tor instead of poly(dI-dC) (Nakamura and Koike, 1992) . Mutation at the SphI site (GCATGC to GACTGC) in the its center. The mutations introduced into this target sequence for X-PBP binding remarkably reduce transcription 20-bp sequence greatly reduced the promoter activity (see pXMP2mCAT), indicating that the CA sequence in from the major start site of CAT mRNA using the BalI/MboI DNA-CAT construct (pX58pCAT) (Nakamura and Koike, the SphI site of 20-bp DNA is essential for the activity. Truncation or deletion of half of the MP2 DNA resulted 1992). Therefore, the binding of X-PBP was shown to be essential for the initiation of X gene transcription. These in loss of the promoter activity (see pX58pM5CAT and pXMP3CAT). The exact reason why pX58pM6 CAT exhibdata indicate an important role of X-PBP in the regulation of X gene expression. To further examine the binding region ited slightly lower activity compared to pX58pM4CAT is not known, but as a result of a deletion, a negative elefor X-PBP, a mobility shift assay was performed using various X gene promoter-containing DNAs. Results indicated ment at the 3 end region was close to the 20-bp sequence and may have had an effect on it. Actually, that M7 DNA, the insert of the pX58pM7CAT plasmid ( Fig.  1) , had the capacity to bind X-PBP. Competition experiments pX58pM7CAT without the 3 end region exhibited higher activity. In addition, pX58pM2CAT, containing a mutation against M7 DNA were then carried out with various deletion mutant DNAs ( Fig. 2A) . A mobility shift assay was also at the SphI site (GCATGC to TTTTTT) in the 58-bp region performed using wild-type or mutant DNAs as the probe (Fig. 2B) . The 20-bp MP2 DNA (nt 1102-1121) was found to be sufficient for the binding of X-PBP, although X-PBP protected a larger area in the DNaseI footprinting experiments (Nakamura and Koike, 1992; Yaginuma et al., 1993) . The point mutant MP2m (the insert of pXMP2mCAT plasmid) showed much reduced X-PBP binding activity (Fig. 2B) , suggesting that the sequence ''CA'' in the SphI site is in the recognition site of X-PBP. MP2m DNA also exhibited much with previous observations (Nakamura and Koike, 1992;  As the basal activity of the reporter plasmid varied (see Fig. 1 ), the amount of the transfected reporter plasmid DNAs was adjusted; 2 mg Yaginuma et al., 1993) .
for MP2 (pXMP2CAT), M4 (pX58pM4CAT), and M7 (pX58pM7CAT), and 10 mg for MP2m (pXMP2mCAT) and MP3 (pXMP3CAT), in order to Activation of the X gene promoter activity by X clarify the difference between the basal and activated promoter activiprotein ties. Similar results were obtained when 10 mg of pEFX was used as the X expression plasmid. Relative activity (RA) for the basal activity of Since X protein is known to activate transcription of each reporter plasmid was calculated and is shown at the top.
many genes through various DNA elements, it was of interest to determine whether X protein is able to activate the X gene promoter. CAT activity assay was performed X-responsive element was present in X gene promoter using various X gene promoter CAT constructs and the and that X protein was able to activate X gene expression X gene expression plasmid (pHBVX-1) or the control plasas long as the promoter activity was detected. When mid (pBR322). As the basal CAT activity of the reporter Northern blot analysis of the CAT mRNA that was explasmid varied (see Fig. 1 ), the amount of each pressed in X gene-transfected or nontransfected cells transfected reporter plasmid DNA was adjusted (2 mg for was carried out, CAT mRNA was found to have increased pXMP2CAT, pX58pM4CAT, and pX58pM7CAT and 10 mg in the X-transfected cells as a function of the amount of for pXMP2mCAT and pXMP3CAT), in order to clearly dis-X gene transfection (data not shown). These data support tinguish the difference in activity between basal and actiour indication that activation of the X gene promoter activvated promoters. Interestingly, transcription from the ity by transfected X gene is not merely caused by overexsmall 20-bp DNA (MP2 or MP2m) was clearly activated by pression of X protein in the transient expression system. X protein, but MP3 was not (Fig. 3) . All reporter plasmids, Next, we investigated whether the X-PBP is directly except pXMP3CAT, were similarly activated by X protein involved in the transactivation function of X protein. A coexpression in their extent. The data indicated that an mutated X gene promoter (MP2m), to which X-PBP was weakly bound (Fig. 2B) , was analyzed for its response to X protein. As shown in Fig. 3 , the mutant pXMP2mCAT was still responsive to transactivation by X protein, although the mutant had much weaker promoter activity (see Fig. 1 ) than that of the wild-type construct (pXMP2CAT), indicating that X-PBP was not a direct mediator of the X protein function. In addition, pX58pM2CAT was tested for its response to X protein, since pX58pM2CAT does not bind X-PBP at all (Nakamura and Koike, 1992) . pX58pM2CAT was transactivated by transfected pHBVX-1 DNA (data not shown). These observations suggest that X promoter activation by X protein is not directly mediated by X-PBP. Northern blot analysis of X mRNA transcribed from the expression plasmid pHBVX-1 or pHBV dimer in the p53-
Repression of X Gene Transcription by Transfected transfected or nontransfected cells was further carried
Tumor Suppressor Gene p53 and Its Mutant out, X mRNA was found to have been reduced in the p53
Relative CAT activity gene-transfected cells (Fig. 4B ). These data support our proposal that repression of X gene promoter activity by nucleotide substitution at the SphI site), to which X-PBP and CAT activity was determined relative to that of the controls. The bound weakly (Fig. 2B) , was analyzed in terms of its vector for the expression plasmid contained the CMV promoter. For response to the p53 protein. As shown in Fig. 4C , the most experiments, the quantity of reporter plasmid containing 58-bp wild-type X promoter (pXMP2CAT) and the mutant X pro-DNA (pX58pCAT) or its mutant (pX58pM1CAT) was 1 mg per dish, that moter (pXMP2mCAT) were similarly responsive to p53 of the expression plasmid was 1 mg per dish, and the corresponding vector was used to adjust the amount of total DNA in each experiment.
repression in their extent, although X-PBP binding activity pEtCAT, a CAT construction of the creatine kinase gene promoter as was much weaker in the mutant than in the wild-type the positive control. DN, amino-terminal deletion (aa 1-159). OM1, (pXMP2CAT), indicating that X-PBP was unlikely to be a point mutation Gly (aa 226) r Glu.
direct mediator of the p53 function. pX58pM2CAT (Nakamura and Koike, 1992) was also tested for its response to p53 repression, since pX58pM2CAT does not bind Xhas neither a p53 binding site nor a TATA box, and Saos-2 cells are known to be p53-negative cells (Masuda et PBP at all because of a five-nucleotide substitution at the SphI site. pX58pM2CAT was also responsive to noral., 1987) . Therefore, we carried out DNA transfection experiments to Saos-2 cells using the BalI/MboI DNAmal p53 protein (data not shown). Thus, repression of the X gene promoter activity by normal p53 protein ap-CAT construct (pX58pCAT) and its mutant pX58pM1CAT, together with normal or mutant p53 expression plasmids pears to be closely correlated with the basal transcription factor. (Table 1) . When normal or mutant p53 gene and pX58pCAT or pX58pM1CAT were cotransfected, normal
To clarify the region of normal p53 protein responsible for the repression of X gene promoter activity, several p53 gene repressed CAT expression, while mutant p53 (p53 mutant DN or OM1) did not and, in contrast, slightly p53 mutants were examined. Consistent with the recent observations by others (Shiio et al., 1992; , stimulated CAT expression for some unknown reason. In other words, transfected normal p53 is able to repress 1992; Sang et al., 1994) , any amino-terminal deletion (DN) or carboxy-terminal deletion (345, 301, or 282) or a X gene promoter activity. Under the same conditions, the creatine kinase gene promoter (pEtCAT) was activated point mutation at the central region (OM1) (Sakai and Tsuchida, 1992) abolished the transcriptional repression by transfected p53 gene (Table 1) , consistent with the previous data (Weintraub et al., 1991; Zambetti et al., function of the p53 protein (Fig. 4D) . We then prepared a nuclear extract from p53-negative 1992).
Although there is no detailed information available yet Saos-2 cells to examine whether X-PBP migrates at a different position in the mobility shift assay without p53 on the kind of basal transcription factor involved in X gene transcription, it was of interest to clarify whether protein. The Saos-2 cell extract showed the same X-PBP band as that from HepG2 cells (Fig. 5A ). In addition, antinormal p53 protein regulates the 20-bp sequence for promoter activity of the X gene. To examine the effect of p53 antibodies (PAb421 or PAb1801) did not supershift or eliminate the X-PBP band (Fig. 5A ). Data so far obtained p53 protein on this minimal promoter sequence, different amounts of the p53 expression plasmid and the constant indicate that the p53 protein is not a major constituent of the X-PBP complex. Therefore, p53 binding to X-PBP amount of reporter plasmid pXMP2CAT containing the 20-bp sequence were cotransfected to HepG2 cells. As was tested using immunopurified normal p53 from the baculovirus expression system and the HepG2 nuclear shown in Fig. 4A , activity of the X gene promoter was clearly repressed by the transfected p53 gene in a doseextract (NE) with or without anti-p53 antibody (PAb421) or anti-SV40 T-Ag antibody (as a control). Any significant dependent manner. On the other hand, transcriptional activation of the creatine kinase gene promoter was obinteraction between X-PBP and normal p53 protein was not detected under the conditions used (Fig. 5B ). To conserved. More specifically, the same amount of p53 expression plasmid brought about more than 15-fold activafirm that our p53 protein retains the sequence-specific DNA binding activity, normal and mutant HOS(156Pro) tion in HepG2 cells (data not shown) or p53-negative Saos-2 cells (Table 1 and Takada et al., 1994b) . When p53 proteins were used with the consensus p53 binding -1) or the HBV genomic plasmid (pHBV-dimer) in the quantity of 10 mg per 10-cm dish was transfected into HuH-7 cells with or without 2 mg per dish of p53 expression plasmid pCMVp53. Total RNAs were analyzed using a 32 P-labeled X gene probe. Later, the same filter was rehybridized with a 32 P-labeled b-actin probe (WAKO Pure Chemical Industry Ltd.) to confirm the amount of blotted RNAs. (C) Mutant X gene promoter at X-PBP binding site preserves response to p53. p53 expression plasmid, pCMVp53 (normal), indicated as / or the control plasmid, pCMV, indicated as 0 (each 2 mg per 10-cm dish), was cotransfected with 10 mg per 10-cm dish of the X gene promoter CAT plasmid (pXMP2CAT) or 10 mg of the point mutant at the X-PBP binding site (pXMP2mCAT). For structures of the reporter plasmids, see Fig. 1 . Relative activity (RA) was calculated and is shown at the top. (D) Inability of mutant p53 to repress the transcription from the X gene promoter. Mutant p53 constructs were tested for their ability to repress transcription of the X gene. Two micrograms per 10-cm dish of mutant p53 expression plasmid was transfected with the reporter plasmid pXMP2CAT (10 mg). Transfected p53 expression plasmids were Vecter, pCMV; Wild, pCMVp53 (normal); 345, 301, 282, ; OM1, pCMVOM1; and DN, pCMVp53DN. Data for the plasmid 301 were introduced from the separate experiment where 301 plasmid exhibited the same level of the activity as the control vector only. DNA in the presence or absence of PAb421, which was the X gene promoter was found to be clearly activated by X protein expression (Fig. 3) , indicating that the Xreported to activate the sequence-specific DNA binding responsive element is present in the X gene promoter of p53 (Hupp et al., 1992) . As also shown in Fig. 5B , the region. Because the X gene promoter activity was regusmall arrowhead to the right indicates the complex of lated negatively by normal p53 protein or positively by normal p53 protein and p53 binding DNA. The large ar-X protein, CAT activity assay was then carried out to rowhead to the right indicates the triple complex of determine the effect of cotransfected X expression plasPAb421, normal p53 protein, and p53 binding DNA. mid on the transcriptional repression function of p53 proThese observations strongly suggest that repression of tein. As shown in Fig. 6, p53 repression of the X gene the X gene promoter activity by normal p53 protein is not promoter activity (pXMP2CAT) was significantly recovmediated through X-PBP.
ered by increasing the amount of cotransfected X gene. This recovery depended on the Kunitz domain-like struc-X protein cancels the transcriptional repression by ture of the X protein, which is essential for the transactitransfected p53 gene vation function of X protein (Takada et al., unpublished As described above, when the CAT plasmid containing data). The data clearly indicated that the p53 transcripwild-type or mutant X promoter was cotransfected with tional repression of X gene promoter activity can be counthe X gene expression plasmid (pHBVX-1) or the control teracted with X protein coexpression in the transient expression system using HepG2 cells. Normal endogenous plasmid (pBR322) into HepG2 cells, transcription from as the chromatin structure or by modification of the DNA (Weintraub, 1985; Ptashne, 1988; Johson and McKnight, 1989) . The amount of transcription factors in cells may also affect the transcription activity (Rechesteiner, 1991) . A difference in responsiveness to X protein seems not to be species-specific or simply tissue-specific (Seto et al., 1989) , so one can speculate that X protein has a repertory of interaction partners, selects an appropriate one among them according to the condition of the cell or the concentration of factors in the cell, and transactivates a specific set of genes in the cell in consequence. Alternatively, X protein may catalytically modify a specific set of transcription factors. Considering the previous observations, it is important to examine interaction between X protein and cellular factors and/or the interaction partner with X protein. Maguire et al. (1991) demonstrated   FIG. 5 . Normal p53 protein was not detected in the X-PBP complex.
that X protein could bind to CREB or ATF-2, making each has been paid to the difference in promoter activity in the presence or absence of X protein. In fact, we also found that X protein activated the core promoter of the p53 protein is probably one dominant determinant of the SV40 early gene (data not shown). Among the elements occurrence of transcriptional activation by the X protein.
for transcription initiation, the TATA box is the most comIt is not certain whether there is a direct interaction bemon sequence with which the transcription factor, TFIID, tween p53 and X protein under the conditions used; however, X protein can up-regulate X gene transcription in the presence of normal p53. This indication was supported by the fact that transactivation of the X gene as well as cellular genes by the X protein can be observed in several different cell lines expressing normal p53, but not in its mutant cell lines (Takada et al., unpublished data; see Discussion) . The activity of transcription is determined for each cotransfected to HepG2 cells and CAT activity assay was carried out gene by transcriptional factors and their responsive eleusing 2 mg of pXMP2CAT as the reporter plasmid. Relative activity (RA) was calculated and is shown at the top. ments in the regulatory DNA region of each gene as well interacts. Another initiation sequence, for instance, the standing the mechanism of X gene transcription. These analyses are currently under investigation. GC box, is also known in a variety of genes. Since no homology has been found between the X-PBP binding Disruption of normal p53 function by X protein and sequence and the known initiation sequences, the setransactivation quence stretch including the X-PBP binding site may be another type of initiator sequence. Although the physioAs we found that the X gene promoter activity was logical function of X-PBP has not yet been fully characternegatively or positively regulated by p53 or X protein, ized, the present data indicate that activation of the X respectively, the transcriptional activation function of X gene promoter activity by X protein is unlikely to be mediprotein may be explained by the interference of normal ated through X-PBP.
p53 function with coexpressed X protein. Recently, sevIt is known that activation by X protein is observed in eral studies have suggested that X protein influenced different degrees according to the cell type (Seto et al., signal transduction pathways; for example, X protein 1989 ; Rossner, 1992) . In this respect, it should be noted stimulated Ras-GTP complex formation and promoted that some of the p53-defective cell lines, such as HuHdownstream signaling through Raf and MAP kinases 7 cells (Bressac et al., 1990) , Cos cells (because of the (Benn and Schneider, 1994; Cross et al., 1993) . It would expression of SV40 T-Ag), and CV-1 cells, when be possible to speculate, therefore, that X protein influtransfected with SV40 T-Ag expression plasmid, exhibences one of the signal pathways, which may affect any ited no transcriptional activation by X protein (Koike et al., of the cytosolic factors involved in the disruption of p53 1989; Spandau and Lee, 1988) . The state of p53 protein is function. probably one of the dominant determinants of cell type
Binding of p53 to its DNA consensus sequence is necspecificity for occurrence of efficient transcriptional actiessary for the transactivation of genes adjacent to these vation by X protein.
binding sites (Kern et al., 1991; Weintraub et al., 1991) . It has also been postulated that normal p53 modulates gene transcription by interacting with the basic transcripTranscriptional repression of X gene promoter by p53 tional machinery, TFIID, a part of the transcription initiaprotein tion complex that has been shown to be a p53 target, p53 was previously demonstrated to interact with the resulting in down-regulation of TFIID-dependent genes TBP-associated factors TAFII40 and TAFII60 when acti- (Seto et al., 1992; Liu et al., 1993) . HBV X protein seems vating transcription through p53 binding DNA (Thut et al., to have such an effect on the p53 suppressor function, 1995) and the basal transcription factor TFIIH (Xiao et similar to that of oncogene products of other DNA tumor al., 1994). Viral and cellular genes have been reported viruses, including SV40 T-antigen, human papilloma virus to be negatively regulated by normal p53 (Deffie et al., E6, and adenovirus E1B. Viral replication may be trig-1993; Shiio et al., 1992; Ginsberg et al., 1991;  Santhanam gered through a disruption of the p53 suppressor funcet al., 1991; Subler et al., 1992) . It was also reported tion by X gene expression without any mutation of p53. that normal p53 binds to TBP and inhibits transcriptional Recently, the in vitro interaction between p53 and X proinitiation by interfering with binding of the basal tranteins was studied by fusing the entire X or normal and scription factors to the TATA motif (Ragimov et al., 1993) . mutant p53 ORFs to the GST (glutathione S-transferase) In this study, we first determined the 20-bp region for X gene (Wang et al., 1994) . Only the GST normal p53, but gene promoter activity, which possesses none of the not GST mutant p53 or GST alone, bound the in vitro typical promoter sequences and then examined whether translated X protein. These results are consistent with normal p53 protein positively or negatively regulated X those of a previously reported study (Feitelson et al. , gene transcription. We demonstrated that the promoter 1993). On the other hand, when the X gene expression activity was repressed by normal p53 under the condiplasmid was cotransfected with the p53 expression plastions used. Although the requirement of TBP for transcripmid into HepG2 cells, we observed the major localization tion from the X gene promoter is unknown because of of X protein in the cytoplasm (Takada et al., unpublished the absence of the TATA motif, the mechanism of represdata). Thereby, the repression function of p53 may be sion of the X gene promoter may involve direct interfercanceled by this cytoplasmic X protein by some unknown ence of TBP function or TFIIH function with normal p53 mechanism in the cotransfected HepG2 cells. Further protein. Normal p53 protein (synthesized and purified elucidation of the mechanism by which X protein, particufrom the baculovirus expression system) exhibited no larly its serine protease inhibitor-like domain (Takada sequence-specific binding activity to this 20-bp promoter and Koike, 1990a) , disrupts the repressor function of p53 DNA under the conditions used (Figs. 5A and B) . We also protein may prove to be fruitful in understanding the observed that X-PBP binding correlated with the X gene pleiotropic effects of X protein. promoter activity (Nakamura and Koike, 1992 ; this paper); ACKNOWLEDGMENTS however, further analyses on the basal transcription factors for the X gene promoter activity and their relationship
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